MedElevator Войти в исследования
← Поиск публикаций

DOI 10.7759/cureus.90354

Медицинская библиотека · Cureus · 2025

A Phase-II Investigator-Initiated Randomized, Double-Blind, Parallel-Group Clinical Trial of 5-Aminolevulinic Acid Hydrochloride/Sodium Ferrous Citrate (5-ALA-HCl/SFC) for Patients With Adult-Onset Still's Disease (AOSD) Refractory to Corticosteroids.

Sumiyoshi Remi, Koga Tomohiro, Kamisawa Osamu, Morimoto Shimpei, Hosogaya Naoki, Yamamoto Hiroshi, Kawakami Mariko, Inaba Yosuke, Hattori Yoko, Hikake Tamiki, Kurokawa Tomoya, Hanaoka Hideki, Sato Shuzo, Migita Kiyoshi, Ogawa Noriyoshi, Hashimoto Motomu, Kawakami Atsushi

СтатьяПеревод в очереди

Аннотация

OBJECTIVE

To evaluate the efficacy and safety of 5-aminolevulinic acid hydrochloride/sodium ferrous citrate (5-ALA-HCl/SFC) in patients with adult-onset Still's disease (AOSD) refractory to corticosteroids.

METHODS/

DESIGN

This multicenter, investigator-initiated, randomized, double-blind, placebo-controlled, parallel-group phase II trial was designed to enroll 30 participants but was prematurely terminated after enrolling four participants because of slow recruitment. Participants were randomized to receive 5-ALA-HCl/SFC (100 or 300 mg/day) or placebo for 8 weeks. The primary endpoint was the achievement of adapted ACR 30 at week 4.

RESULTS

All four enrolled participants achieved adapted ACR 30 at week 4. Adapted ACR 50/ 70/ 90 responses and improvements in systemic feature score, serum ferritin, and quality of life varied among individuals. No serious adverse events were observed.

CONCLUSION

Efficacy signals were observed, especially in the high-dose group; however, the small sample size precludes definitive conclusions. Further research is required to confirm this.

Для цитирования: Sumiyoshi Remi, Koga Tomohiro, Kamisawa Osamu, Morimoto Shimpei, Hosogaya Naoki, Yamamoto Hiroshi, Kawakami Mariko, Inaba Yosuke, Hattori Yoko, Hikake Tamiki, Kurokawa Tomoya, Hanaoka Hideki, Sato Shuzo, Migita Kiyoshi, Ogawa Noriyoshi, Hashimoto Motomu, Kawakami Atsushi. A Phase-II Investigator-Initiated Randomized, Double-Blind, Parallel-Group Clinical Trial of 5-Aminolevulinic Acid Hydrochloride/Sodium Ferrous Citrate (5-ALA-HCl/SFC) for Patients With Adult-Onset Still's Disease (AOSD) Refractory to Corticosteroids.. Cureus. 2025. DOI: 10.7759/cureus.90354.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.